Clozapine and full-dose concomitant chemoradiation therapy in a schizophrenic patient with nasopharyngeal cancer

Tumori

Volumn 88, Issue 1, 2002, Pages 59-60

  Bareggi, Claudia ^a   Palazzi, Mauro ^a   Locati, Laura D ^a   Cerrotta, Annamaria ^a   Licitra, Lisa ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Chemoradiation; Clozapine; Neutropenia

Indexed keywords

CISPLATIN; CLOZAPINE;

ADULT; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOPENIA; MALE; NASOPHARYNX CANCER; NAUSEA; NEUTROPENIA; SCHIZOPHRENIA; TREATMENT OUTCOME; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; ANTIPSYCHOTIC AGENTS; CISPLATIN; CLOZAPINE; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; NEUTROPENIA; RADIOTHERAPY DOSAGE; SCHIZOPHRENIA;

EID: 0036211219     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Adverse effects of antipsychotic agents. Do newer agents offer advantages?
2. Antipsychotics. Part II. Atypical Adverse effects, drug interactions, and costs
3. Continuing clozapine despite neutropenia
4. Clozapine and chemotherapy
5. Clozapine, cancer, and schizophrenia